1.Zhou B, Bentham J, Di Cesare M, Bixby H, Danaei G, Cowan MJ, Paciorek CJ, Singh G, Hajifathalian K, Bennett JE: Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19· 1 million participants. The Lancet 2017, 389(10064):37–55.
2.Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: analysis of worldwide data. The lancet 2005, 365(9455):217–223.
3.Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Khajeh E, Asgari F, Noshad S, Rafei A, Mousavizadeh M et al: Awareness, treatment and control of pre-hypertension, and hypertension among adults in Iran. Archives of Iranian Medicine 2016, 19(7):456–464.
4.Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Himmelfarb CD, DePalma SM, Gidding S, Jamerson KA, Jones DW: 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology 2017:24430.
5.Ihm SH, Bakris G, Sakuma I, Sohn IS, Koh KK: Controversies in the 2017 ACC/AHA Hypertension Guidelines: Who Can Be Eligible for Treatments Under the New Guidelines?- An Asian Perspective. Circ J 2018.
6.James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O: 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). Jama 2014, 311(5):507–520.
7.Li D, Zeng X, Huang Y, Lei H, Li G, Zhang N, Huang W: Increased Risk of Hypertension in Young Adults in Southwest China: Impact of the 2017 ACC/AHA High Blood Pressure Guideline. Current hypertension reports 2019, 21(3):21.
8.Watkins DA: Implications of the 2017 ACC/AHA Hypertension Guideline for Public Health in NepalThe 2017 ACC/AHA Hypertension Guideline and Public Health in NepalInvited Commentary. JAMA Network Open 2018, 1(3):e180778-e180778.
9.World Health Organization: STEPS instruments for NCD risk factors (core and expanded version 1.4): the WHO STEPwise approach to Surveillance of noncommunicable diseases (STEPS). In.: Geneva: World Health Organization; 2001.
10.Djalalinia S, Modirian M, Sheidaei A, Yoosefı M, Zokaiee H, Damirchilu B, Mahmoudi Z, Mahmoudi N, Hajipour MJ, Peykari N: Protocol Design for Large—Scale Cross—Sectional Studies of Surveillance of Risk Factors of Non—Communicable Diseases in Iran: STEPs 2016. Archives of Iranian Medicine (AIM) 2017, 20(9).
11.Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J: Prevalence, awareness, treatment, and control of hypertension in China: data from 1· 7 million adults in a population-based screening study (China PEACE Million Persons Project). The Lancet 2017, 390(10112):2549–2558.
12.Rutstein SO, Johnson K, MEASURE OM: The DHS wealth index: ORC Macro, MEASURE DHS; 2004.
13.Rezaei S, Mahmoudi Z, Sheidaei A, Aryan Z, Mahmoudi N, Gohari K, Yoosefi M, Hajipour MJ, Dilmaghani-Marand A, Soleimanzadehkhayat M: Salt intake among Iranian population: the first national report on salt intake in Iran. Journal of hypertension 2018, 36(12):2380–2389.
14.Jette M, Sidney K, Blümchen G: Metabolic equivalents (METS) in exercise testing, exercise prescription, and evaluation of functional capacity. Clinical cardiology 1990, 13(8):555–565.
15.Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Journal of the American College of Cardiology 2018:25709.
16.Association AD: 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes care 2018, 41(Supplement 1):S13-S27.
17.Khera R, Lu Y, Lu J, Saxena A, Nasir K, Jiang L, Krumholz HM: Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study. bmj 2018, 362:k2357.
18.Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright Jr JT, Whelton PK: Potential US population impact of the 2017 ACC/AHA high blood pressure guideline. Circulation 2018, 137(2):109–118.
19.Cifkova R, Fodor G, Wohlfahrt P: Changes in hypertension prevalence, awareness, treatment, and control in high-, middle-, and low-income countries: an update. Current hypertension reports 2016, 18(8):62.
20.Dastan I, Erem A, Cetinkaya V: Awareness, treatment, control of hypertension, and associated factors: Results from a Turkish national study. Clinical and Experimental Hypertension 2018, 40(1):90–98.
21.Matar D, Frangieh AH, Abouassi S, Bteich F, Saleh A, Salame E, Kassab R, Azar RR: Prevalence, awareness, treatment, and control of hypertension in Lebanon. Journal of Clinical Hypertension 2015, 17(5):381–388.
22.Abdul-Razak S, Daher AM, Ramli AS, Ariffin F, Mazapuspavina MY, Ambigga KS, Miskan M, Abdul-Hamid H, Mat-Nasir N, Nor-Ashikin MNK et al: Prevalence, awareness, treatment, control and socio demographic determinants of hypertension in Malaysian adults. BMC Public Health 2016, 16(1).
23.Ab Majid NL, Omar MA, Khoo YY, Mahadir Naidu B, Ling Miaw Yn J, Rodzlan Hasani WS, Mat Rifin H, Abd Hamid HA, Robert Lourdes TG, Mohd Yusoff MF: Prevalence, Awareness, Treatment and Control of hypertension in the Malaysian population: findings from the National Health and Morbidity Survey 2006–2015. Journal of Human Hypertension 2018, 32(8–9):617–624.
24.Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, Khammash U, Alshamiri MQ, Rangarajan S, Yusuf S: Prevalence, awareness, treatment and control of hypertension in four Middle East countries. Journal of hypertension 2017, 35(7):1457–1464.
25.Lee JH, Kim S-H, Kang S-H, Cho JH, Cho Y, Oh I-Y, Yoon C-H, Lee H-Y, Youn T-J, Chae I-H: Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline. Scientific reports 2018, 8(1):13155.
26.Organization WH: Guideline: Sodium intake for adults and children: World Health Organization; 2012.
27.Liu K, Colangelo LA, Daviglus ML, Goff DC, Pletcher M, Schreiner PJ, Sibley CT, Burke GL, Post WS, Michos ED: Can antihypertensive treatment restore the risk of cardiovascular disease to ideal levels? The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi‐Ethnic Study of Atherosclerosis (MESA). Journal of the American Heart Association 2015, 4(9):e002275.
28.Census 2016 - Detailed Results [https://www.amar.org.ir]
29.Brouwer ED, Watkins D, Olson Z, Goett J, Nugent R, Levin C: Provider costs for prevention and treatment of cardiovascular and related conditions in low-and middle-income countries: a systematic review. BMC Public Health 2015, 15(1):1183.
30.Mohammadi E: Evaluating impacts of the Iran’s Health Transformation Plan on the National Health Insurance System In. Tehran: National Institute of Health Research 2015.
31.Sadeghi-Ghyassi F, Mostafaie A, Hajebrahimi S, Ghojazadeh M, Mostafaie H: Ophthalmologist knowledge of evidence-based medicine and clinical practice guideline recommendations. Evidence Based Medicine 2016.
32.Nambisan P, Nambisan S: Models of consumer value cocreation in health care. Health Care Management Review 2009, 34(4):344–354.
33.Frow P, McColl-Kennedy JR, Payne A: Co-creation practices: Their role in shaping a health care ecosystem. Industrial Marketing Management 2016, 56:24–39.
34.Denyer D, Tranfield D, Van Aken JE: Developing design propositions through research synthesis. Organization studies 2008, 29(3):393–413.
35.Mahdavi M, Vissers J, Elkhuizen S, van Dijk M, Vanhala A, Karampli E, Faubel R, Forte P, Coroian E, van de Klundert J: The relationship between context, structure, and processes with outcomes of 6 regional diabetes networks in Europe. PloS one 2018, 13(2):e0192599.